Price $4.60 |
Market Cap
108M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
2.93
|
P/S
0.33
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
98.8
|
Op. Cash Flow
3.8K
|
FCF
0.0
|
|
Op. Margin
-21.90%
|
Net Margin
-27.30%
|
ROE
-149.40%
|
ROI
-17.30%
|
|
ROA
-17.50%
|
EPS Growth
3.40%
|
Current Ratio
1.2
|
Debt/Equity
625.10%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Harrow Health Inc (HROW) | $11.52 | - | - | 180.6M | Strong Buy |
| Aerie Pharmaceuticals Inc (AERI) | $15.12 | - | - | 371.5M | Strong Buy |
| Medicine Man Technologies Inc (SHWZ) | $1.03 | - | - | 52.7M | Strong Buy |
| VolitionRX Ltd (VNRX) | $1.44 | - | - | 116.8M | Strong Buy |
| Lineage Cell Therapeutics Inc (LCTX) | $1.15 | - | - | 285.1M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
